ALMIB — Amoeba SA Income Statement
0.000.00%
Last trade - 00:00
- €22.77m
- €20.30m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.122 | 0.122 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0.115 | -0.209 | -0.35 | -0.358 | -0.366 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6.2 | 5.63 | 6.16 | 5.58 | 6.15 |
Operating Profit | -6.07 | -5.51 | -6.16 | -5.58 | -6.15 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.22 | -7.25 | -8.16 | -7.82 | -8.02 |
Net Income After Taxes | -7.22 | -7.25 | -8.16 | -7.82 | -8.02 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.22 | -7.25 | -8.16 | -7.82 | -8.02 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.22 | -7.25 | -8.16 | -7.82 | -8.02 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.1 | -0.919 | -0.503 | -0.44 | -0.23 |
Dividends per Share |